Stock Events

Enovis 

R$58.35
14
+R$0+0% Monday 20:05

Statistics

Day High
58.35
Day Low
58.35
52W High
80.96
52W Low
58.35
Volume
46
Avg. Volume
19
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
0.37
0.51
0.65
0.79
Expected EPS
0.62
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow E2NO34.SA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Smith & Nephew
SNN
Mkt Cap13.45B
Smith & Nephew competes directly with Enovis in the orthopedics segment, offering similar products for joint replacement and repair.
Stryker
SYK
Mkt Cap137.35B
Stryker is a major competitor in the medical technology field, particularly in orthopedics, surgical equipment, and neurotechnology, directly competing with Enovis' product lines.
Zimmer Biomet
ZBH
Mkt Cap23.51B
Zimmer Biomet Holdings, Inc. is a direct competitor in the orthopedic device market, offering a wide range of products for joint reconstruction, similar to Enovis.
Medtronic
MDT
Mkt Cap113.61B
Medtronic competes with Enovis in multiple areas, including surgical products and patient monitoring systems, making it a broad competitor.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson, through its medical devices segment, competes across several areas with Enovis, including surgical products and orthopedics.
Boston Scientific
BSX
Mkt Cap120.45B
Boston Scientific Corporation offers products in various medical fields that overlap with Enovis' offerings, including surgical and orthopedic devices.
Abbott Laboratories
ABT
Mkt Cap197.08B
Abbott Laboratories competes with Enovis through its range of medical devices, including vascular and neuromodulation devices, overlapping with Enovis' market.
Globus Medical
GMED
Mkt Cap9.84B
Globus Medical, Inc. competes in the spine orthopedic devices market, offering innovative solutions that rival Enovis' spine-focused products.
Integra Lifesciences
IART
Mkt Cap1.58B
Integra LifeSciences Holdings Corporation offers products in orthopedics and tissue technologies, competing with Enovis in the surgical and orthopedic device market.

About

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Show more...
CEO
Mr. Mitchell P. Rales
Employees
16200
Country
United States
ISIN
BRE2NOBDR001

Listings